MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
RNAC Cartesian Therapeutics
- 19.020
- -0.250-1.30%
Close Dec 20 16:00 ET
- 19.020
- -0.0010.00%
Post 16:30 ET
483.39MMarket Cap-0.41P/E (TTM)
19.880High18.730Low778.47KVolume18.960Open19.270Pre Close14.84MTurnover8.90%Turnover RatioLossP/E (Static)25.41MShares41.87052wk High634.00P/B166.42MFloat Cap11.66552wk Low--Dividend TTM8.75MShs Float728.003Historical High--Div YieldTTM5.97%Amplitude11.665Historical Low19.058Avg Price1Lot Size
Cartesian Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 22, 2024
The average Cartesian Therapeutics stock price target is 37.80 with a max estimate of 45.00 and a min estimate of 22.00
Review Cartesian Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 22, 2024